Search research articles
Contact Us
Filters
Showing results (21-30 of 174) with videos related to
Page
of 18
Sort By:
The Cochrane Database of Systematic Reviews
|
October 8, 2019
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Felicia Roncolato, Kristina Lindemann, Melina L Willson, et al.
Chest
|
November 16, 2016
In Replay: Psychiatric Morbidity in Patients with Lung Cancer
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Chest
|
May 18, 2013
Suicide in lung cancer: who is at risk?
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Gynecologic Oncology
|
December 15, 2022
Prognostic significance of FIGO 2018 staging of loco-regionally advanced cervical cancer (LRACC) with the use of MRI and PET and implications for treatment selection
Ming Yin Lin, Linda Mileshkin, Orla McNally, et al.
ESMO Open
|
August 2, 2017
Discussing and prescribing expensive unfunded anticancer drugs in Australia
Deme John Karikios, Linda Mileshkin, Andrew Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 16, 2010
What should a support program for people with lung cancer look like? Differing attitudes of patients and support group facilitators
Bianca Devitt, Allison Hatton, Carl Baravelli, et al.
Chest
|
March 5, 2014
Response
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 6, 2016
Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer
Michael Friedlander, Susana Banerjee, Linda Mileshkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Discussing expensive anticancer drugs
Michael Jefford, Linda Mileshkin, Penelope Schofield, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2013
Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype
Maroie Barkati, Israël Fortin, Linda Mileshkin, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 174) with videos related to
Sort By:
Page
of 18
The Cochrane Database of Systematic Reviews
|
October 8, 2019
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Felicia Roncolato, Kristina Lindemann, Melina L Willson, et al.
Chest
|
November 16, 2016
In Replay: Psychiatric Morbidity in Patients with Lung Cancer
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Chest
|
May 18, 2013
Suicide in lung cancer: who is at risk?
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Gynecologic Oncology
|
December 15, 2022
Prognostic significance of FIGO 2018 staging of loco-regionally advanced cervical cancer (LRACC) with the use of MRI and PET and implications for treatment selection
Ming Yin Lin, Linda Mileshkin, Orla McNally, et al.
ESMO Open
|
August 2, 2017
Discussing and prescribing expensive unfunded anticancer drugs in Australia
Deme John Karikios, Linda Mileshkin, Andrew Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 16, 2010
What should a support program for people with lung cancer look like? Differing attitudes of patients and support group facilitators
Bianca Devitt, Allison Hatton, Carl Baravelli, et al.
Chest
|
March 5, 2014
Response
Damien Urban, Aparna Rao, Mathias Bressel, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 6, 2016
Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer
Michael Friedlander, Susana Banerjee, Linda Mileshkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Discussing expensive anticancer drugs
Michael Jefford, Linda Mileshkin, Penelope Schofield, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2013
Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype
Maroie Barkati, Israël Fortin, Linda Mileshkin, et al.
Page
of 18